References
- Hoffmann A, Chockalingam P, Balint OH et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart 96(15), 1223–1226 (2010).
- Desimone CV, Friedman PA, Noheria A et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation 128(13), 1433–1441 (2013).
- Khairy P, Landzberg MJ, Gatzoulis MA et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation 113(20), 2391–2397 (2006).
- McQuillen PS, Barkovich AJ, Hamrick SE et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke 38( 2 Suppl.), 736–741 (2007).
- de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J. Thorac. Cardiovasc. Surg. 96(5), 682–695 (1988).
- Khairy P, Fernandes SM, Mayer JE, Jr. et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117(1), 85–92 (2008).
- Khairy P, Poirier N. The extracardiac conduit is not the preferred Fontan approach for patients with univentricular hearts. Circulation 126(21), 2516–2525 (2012).
- Valente AM, Bhatt AB, Cook S et al. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J. Am. Coll. Cardiol. 56(2), 144–150 (2010).
- Tomita H, Yamada O, Ohuchi H et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol. Young 11(1), 62–66 (2001).
- Ravn HB, Hjortdal VE, Stenbog EV et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1), 61–65 (2001).
- Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: executive summary. J. Am. Coll. Cardiol. 52(23), 1890–1947 (2008).
- Monagle P, Cochrane A, Roberts R et al. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J. Am. Coll. Cardiol. 58(6), 645–651 (2011).
- Potter BJ, Leong-Sit P, Fernandes SM et al. Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int. J. Cardiol. doi:10.1016/j.ijcard.2013.06.058 (2013) ( Epub ahead of print).
- Engelfriet P, Boersma E, Oechslin E et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. Eur. Heart J. 26, 2325–2333 (2005).
- Bouchardy J, Therrien J, Pilote L et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 120(17), 1679–1686 (2009).
- Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am. J. Cardiol. 86(10), 1111–1116 (2000).
- Khairy P, Aboulhosn J, Gurvitz MZ et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 122(9), 868–875 (2010).
- Feltes TF, Friedman RA. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J. Am. Coll. Cardiol. 24(5), 1365–1370 (1994).
- Ammash NM, Phillips SD, Hodge DO et al. Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease. Int. J. Cardiol. 154(3), 270–274 (2012).
- McCrindle BW, Manlhiot C, Cochrane A et al. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J. Am. Coll. Cardiol. 61(3), 346–353 (2013).